214 related articles for article (PubMed ID: 29534985)
1. Next Generation Endovascular Therapies in Peripheral Artery Disease.
Bunte MC; Shishehbor MH
Prog Cardiovasc Dis; 2018; 60(6):593-599. PubMed ID: 29534985
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.
Lichtenberg MK; Carr JG; Golzar JA
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):518-527. PubMed ID: 28382804
[TBL] [Abstract][Full Text] [Related]
3. Navigating complex femoropopliteal and infrapopliteal anatomy in endovascular interventions.
Bahia A; Lahsaei S; Bhat T; Garcia L
J Cardiovasc Surg (Torino); 2017 Oct; 58(5):690-697. PubMed ID: 28471153
[TBL] [Abstract][Full Text] [Related]
4. Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.
Armstrong EJ; Bishu K; Waldo SW
Curr Cardiol Rep; 2016 Apr; 18(4):34. PubMed ID: 26915012
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
Mohr PJ; Oyama JK; Luu JT; Stinis CT
Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
[TBL] [Abstract][Full Text] [Related]
6. In-stent restenosis management: the best is yet to come.
van den Berg JC
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039
[TBL] [Abstract][Full Text] [Related]
7. Stent-based revascularization for complex lesions in PAD.
d'SOUZA J; Giri J; Kobayashi T
J Cardiovasc Surg (Torino); 2017 Oct; 58(5):715-721. PubMed ID: 28471154
[TBL] [Abstract][Full Text] [Related]
8. Lower extremity computed tomography angiography can help predict technical success of endovascular revascularization in the superficial femoral and popliteal artery.
Itoga NK; Kim T; Sailer AM; Fleischmann D; Mell MW
J Vasc Surg; 2017 Sep; 66(3):835-843.e1. PubMed ID: 28502550
[TBL] [Abstract][Full Text] [Related]
9. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
[TBL] [Abstract][Full Text] [Related]
10. Drug eluting stents and modern stent technologies for in-stent restenosis.
Werner M
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):497-500. PubMed ID: 28382805
[TBL] [Abstract][Full Text] [Related]
11. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee.
Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
Catheter Cardiovasc Interv; 2015 Oct; 86(4):611-25. PubMed ID: 26256456
[TBL] [Abstract][Full Text] [Related]
12. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
13. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
[TBL] [Abstract][Full Text] [Related]
14. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
15. Below-the-ankle angioplasty and stenting for limb salvage: anatomical considerations and long-term outcomes.
Katsanos K; Diamantopoulos A; Spiliopoulos S; Karnabatidis D; Siablis D
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):926-35. PubMed ID: 23152042
[TBL] [Abstract][Full Text] [Related]
16. Vascular elastography: a novel method to characterize occluded lower limb arteries prior to endovascular therapy.
Takimura H; Hirano K; Muramatsu T; Tsukahara R; Ito Y; Sakai T; Ishimori H; Nakano M; Yamawaki M; Araki M; Kato T; Kobayashi N; Sakamoto Y; Ishii A; Takama T; Tokuda T
J Endovasc Ther; 2014 Oct; 21(5):654-61. PubMed ID: 25290793
[TBL] [Abstract][Full Text] [Related]
17. Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease.
Fujihara M; Takahara M; Sasaki S; Nanto K; Utsunomiya M; Iida O; Yokoi Y
J Endovasc Ther; 2017 Jun; 24(3):367-375. PubMed ID: 28351208
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
Barkat M; Torella F; Antoniou GA
Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
[TBL] [Abstract][Full Text] [Related]
20. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.
Ho KJ; Devlin PM; Madenci AL; Semel ME; Gravereaux EC; Nguyen LL; Belkin M; Menard MT
J Vasc Surg; 2017 Mar; 65(3):734-743. PubMed ID: 27986482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
